Reuters: Regulatory News: US FDA approves first generic versions of Merck's Singulair

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

US FDA approves first generic versions of Merck's Singulair Aug 3rd 2012, 19:32 WASHINGTON | Fri Aug 3, 2012 3:32pm EDT WASHINGTON Aug 3 (Reuters) - The U.S. Food and Drug Administration on Friday said it has approved the first generic versions of Merck & Co Inc's Singulair for use in adults and children to control asthma symptoms and relieve both indoor and outdoor allergies.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions